Bio Green Med Solution (BGMS) Net Income towards Common Stockholders (2016 - 2025)
Historic Net Income towards Common Stockholders for Bio Green Med Solution (BGMS) over the last 17 years, with Q3 2025 value amounting to -$2.5 million.
- Bio Green Med Solution's Net Income towards Common Stockholders fell 2789.98% to -$2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.0 million, marking a year-over-year increase of 4826.79%. This contributed to the annual value of -$11.2 million for FY2024, which is 5072.95% up from last year.
- As of Q3 2025, Bio Green Med Solution's Net Income towards Common Stockholders stood at -$2.5 million, which was down 2789.98% from -$1.3 million recorded in Q2 2025.
- Over the past 5 years, Bio Green Med Solution's Net Income towards Common Stockholders peaked at -$81000.0 during Q1 2025, and registered a low of -$7.5 million during Q4 2022.
- Moreover, its 5-year median value for Net Income towards Common Stockholders was -$4.6 million (2022), whereas its average is -$4.1 million.
- Per our database at Business Quant, Bio Green Med Solution's Net Income towards Common Stockholders crashed by 17779.53% in 2021 and then skyrocketed by 9725.05% in 2025.
- Quarter analysis of 5 years shows Bio Green Med Solution's Net Income towards Common Stockholders stood at -$4.9 million in 2021, then tumbled by 51.99% to -$7.5 million in 2022, then grew by 28.76% to -$5.3 million in 2023, then surged by 42.64% to -$3.1 million in 2024, then rose by 17.99% to -$2.5 million in 2025.
- Its Net Income towards Common Stockholders stands at -$2.5 million for Q3 2025, versus -$1.3 million for Q2 2025 and -$81000.0 for Q1 2025.